Schizophrenia

High-potency cannabis and incident psychosis: correcting the causal assumption

Scientists offer a strong counter-position to the belief that cannabis causes psychosis, pointing out the difference between correlation and causation. They argue that smoke exposure from any source (including cigarettes) could explain the reported link between cannabis and psychosis. 

View this review (yellow link) or download:

This paper is also stored here:    http://bit.ly/2WHtDr8     inside the CED Foundation Archive

To explore related information, click keywords below:

Benjamin Caplan, MDHigh-potency cannabis and incident psychosis: correcting the causal assumption
read more

A 2018 study finds that cannabis can alleviate symptoms of medications used for chronic pain as well as serve as an alternative treatment for seizures, pain, and inflammation.

Benjamin Caplan, MDA 2018 study finds that cannabis can alleviate symptoms of medications used for chronic pain as well as serve as an alternative treatment for seizures, pain, and inflammation.
read more

Does cannabis cause psychosis? Evidence is lacking, scientists say

A study in March found that daily use of high-potency cannabis is “strongly linked to the risk of developing psychosis.” But on June 1st, six scientists published a study in The Lancet, a British medical journal, that disputed this claim. The authors of the study note that correlation doesn’t equal causation. In other words, people with schizophrenia may be more likely to use cannabis, but there’s no evidence to suggest that it works the other way around. #psychosis #schizophrenia
The news: http://bit.ly/2WeuM9E
The articles & academic commentary: http://bit.ly/2Wf04wT

Benjamin Caplan, MDDoes cannabis cause psychosis? Evidence is lacking, scientists say
read more

A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia

CBD Shows Promise for Schizophrenia, Alzheimer’s, and Brain Injury Patients

A meta-analysis of previous studies investigating cannabidiol’s (CBD) potential to improve cognitive function among schizophrenia and brain injury patients offers hope to doctors and patients. In experiments on both human patients and rat models of schizophrenia, Alzheimer’s Disease, hypoxic-ischemic brain injury, hepatic encephalopathy, sepsis, pneumococcal meningitis, and cerebral malaria, the administration of CBD reduced neuroinflammation and resulting deficits in spatial learning and memory, recognition memory, and associative learning. Read more or download PDF on the CED Foundation Archive: http://bit.ly/2W1PpW8

In this same review, further investigating the effect of the non-psychoactive cannabidiol (CBD) on cognitive function suggests CBD counteracts the cognitive deficiencies induced by the psychoactive component of cannabis, delta-9-tetrahydrocannabinol (THC). Studies performed on humans and rat models demonstrated that CBD can improve episodic and recognition memory, verbal and visual learning and memory, and working memory, all skills which are usually impaired by THC content. For patients looking to reduce the aforementioned undesirable effects of cannabis, strains or products with high CBD and low THC content may be a viable solution.

Benjamin Caplan, MDA systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
read more

CBD Shows Potential for Schizophrenia Treatment

Research on schizophrenia-affected rat models shows potential for #CBD to minimize many #schizophrenia symptoms

Cannabidiol (CBD) may have potential as a schizophrenia therapeutic agent. Individuals with schizophrenia exhibit decreased activity in choline acetyltransferase (ChAT) activity, an enzyme associated with cognitive functioning. In rat models mimicking schizophrenia, affected rats treated with CBD exhibited normal ChAt activity, while their untreated counterparts exhibited reduced activity.   

CED Foundation Google Drive:  http://bit.ly/2HHWW8E

Read Here or Download:

Benjamin Caplan, MDCBD Shows Potential for Schizophrenia Treatment
read more